Side-by-side comparison of AI visibility scores, market position, and capabilities
11M+ customers 2024, $280M revenue 2024 (+42% YoY), ExtraCash advance product, $4B valuation, SPAC 2022
Dave Inc. was founded in 2017 in Los Angeles by Jason Wilk, John Wolanin, and Paras Chitrakar with the mission of building banking for the people — specifically targeting the tens of millions of Americans living paycheck to paycheck who are underserved or harmed by traditional banking overdraft fees. Dave launched as an app-based overdraft protection service before expanding into a full challenger banking platform, becoming one of the most downloaded fintech apps in the United States.\n\nDave's flagship product is ExtraCash, a small-dollar cash advance feature that allows members to access up to $500 interest-free between paychecks, with repayment tied to the next direct deposit. Alongside ExtraCash, Dave offers a checking account, a debit card, and tools for budgeting, side hustle income discovery, and credit-building. The platform is designed around the financial realities of hourly and gig workers, with no minimum balance requirements, no overdraft fees, and an optional tipping model for cash advances that avoids the regulatory complexity of traditional lending.\n\nDave reported 2024 revenue of $280M, a 42% year-over-year increase, serving 11M+ customers. The company went public via SPAC in 2022 and carries a $4B valuation. Its rapid revenue growth reflects strong product-market fit in the cash advance and challenger banking segment, where Dave competes with Chime, MoneyLion, and Earnin. Dave's focus on the financially underserved, combined with its expanding product suite and improving unit economics, positions it as a durable player in the democratized banking movement.
a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.
a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.